Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/09 → 31/01/10 |
Funding
- Pfizer (Australia) (trading as Pfizer Australia Pty Limited): A$50,000.00
Improving outcomes in patients with Type 2 Diabetes and Chronic Kidney Disease by defining the relationship between glycated haemaglobin and mean glucose.
- Lui, Michelle (Primary Chief Investigator (PCI))
- Teede, Helena (Chief Investigator (CI))
- Zoungas, Sophia (Chief Investigator (CI))
Project: Research